from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3550/echA20

LFCtreatmentdescriptionclass of inhibitor

-0.108

Amikacinug/mL Amikacintranslation

0.186

Cap5-10ug/mL Capreomycintranslation

0.084

Rox10-50 ug/mL Roxithromycintranslation

-0.220

SM2-5 ug/mL Streptomycintranslation

0.000

Tet5-10 ug/mL Tetracyclinetranslation

-0.009

Rif0.2-5ug/mL Rifampicintranscription

0.123

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.668

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.315

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.801

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.639

Clofazimine10-13 ug/mL Clofaziminerespiration

0.289

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

3.089

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.383

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.246

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.200

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.231

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

2.001

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.713

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.063

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-0.206

Nigericin50 uM Nigericinrespiration

0.261

TRC10-150 ug/mL Triclosanrespiration

-0.658

TRZ10-25 ug/mL Thioridazinerespiration

-0.240

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.672

menadione6-10 ug/mL Menadionerespiration

1.827

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.269

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.131

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.504

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.599

NRP_1Non-replicating persistence stage 1dosRassociated

0.236

Amp0.2mg/mL AmpicillincellWall

-0.613

Cephalexin20-100 ug/mL CephalexincellWall

0.730

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.587

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.204

EMB10-20 ug/mL EthambutolcellWall

0.178

Eta12-40 ug/mL EthionamidecellWall

-0.496

INH0.2-0.4 ug/mL IsoniazidcellWall

0.059

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.297

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.624

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.081

BZA0.12 mg/mL BenzamidearomaticAmides

0.020

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.115

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.288

H2O24 mM hydrogen peroxideDNAdamaging

-0.198

Levo10 ug/mL LevofloxacinDNAdamaging

-0.541

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.039

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.055

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.270

UVUV-irradiationDNAdamaging

-1.057

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.389

Antimycin12.5-50 ug/mL Antimycin A?

-0.089

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.110

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.182

PA_2110-50 ug/mL Antitubercular compound PA-21?

2.257

PA8240.2-2 ug/mL PA-824?

1.168

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.664

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.146

Verapamil50 uM Verapamil?

-0.615

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.329

methoxatin10-20 ug/mL Methoxatin?